Publications (14)
The Brain Tumor Segmentation (BraTS) Challenge: Local Synthesis of Healthy Brain Tissue via Inpainting
Florian Kofler, Felix Meissen, Felix Steinbauer +103
A myriad of algorithms for the automatic analysis of brain MR images is available to support clinicians in their decision-making. For brain tumor patients, the image acquisition ti…
The Brain Tumor Segmentation in Pediatrics (BraTS-PEDs) Challenge: Focus on Pediatrics (CBTN-CONNECT-DIPGR-ASNR-MICCAI BraTS-PEDs)
Anahita Fathi Kazerooni, Nastaran Khalili, Xinyang Liu +68
Pediatric tumors of the central nervous system are the most common cause of cancer-related death in children. The five-year survival rate for high-grade gliomas in children is less…
The Brain Tumor Segmentation (BraTS) Challenge 2023: Glioma Segmentation in Sub-Saharan Africa Patient Population (BraTS-Africa)
Maruf Adewole, Jeffrey D. Rudie, Anu Gbadamosi +48
Gliomas are the most common type of primary brain tumors. Although gliomas are relatively rare, they are among the deadliest types of cancer, with a survival rate of less than 2 ye…
Analysis of the 2024 BraTS Meningioma Radiotherapy Planning Automated Segmentation Challenge
Dominic LaBella, Valeriia Abramova, Mehdi Astaraki +102
The 2024 Brain Tumor Segmentation Meningioma Radiotherapy (BraTS-MEN-RT) challenge aimed to advance automated segmentation algorithms using the largest known multi-institutional da…
The 2024 Brain Tumor Segmentation (BraTS) Challenge: Glioma Segmentation on Post-treatment MRI
Maria Correia de Verdier, Rachit Saluja, Louis Gagnon +82
Gliomas are the most common malignant primary brain tumors in adults and one of the deadliest types of cancer. There are many challenges in treatment and monitoring due to the gene…
Analysis of the BraTS 2023 Intracranial Meningioma Segmentation Challenge
Dominic LaBella, Ujjwal Baid, Omaditya Khanna +119
We describe the design and results from the BraTS 2023 Intracranial Meningioma Segmentation Challenge. The BraTS Meningioma Challenge differed from prior BraTS Glioma challenges in…
The Brain Tumor Segmentation (BraTS) Challenge 2023: Focus on Pediatrics (CBTN-CONNECT-DIPGR-ASNR-MICCAI BraTS-PEDs)
Anahita Fathi Kazerooni, Nastaran Khalili, Xinyang Liu +70
Pediatric tumors of the central nervous system are the most common cause of cancer-related death in children. The five-year survival rate for high-grade gliomas in children is less…
Analysis of the MICCAI Brain Tumor Segmentation -- Metastases (BraTS-METS) 2025 Lighthouse Challenge: Brain Metastasis Segmentation on Pre- and Post-treatment MRI
Nazanin Maleki, Raisa Amiruddin, Ahmed W. Moawad +240
Despite continuous advancements in cancer treatment, brain metastatic disease remains a significant complication of primary cancer and is associated with an unfavorable prognosis.…
The Brain Tumor Segmentation (BraTS-METS) Challenge 2023: Brain Metastasis Segmentation on Pre-treatment MRI
Ahmed W. Moawad, Anastasia Janas, Ujjwal Baid +229
The translation of AI-generated brain metastases (BM) segmentation into clinical practice relies heavily on diverse, high-quality annotated medical imaging datasets. The BraTS-METS…
The Brain Tumor Segmentation (BraTS) Challenge 2023: Brain MR Image Synthesis for Tumor Segmentation (BraSyn)
Hongwei Bran Li, Gian Marco Conte, Qingqiao Hu +62
Automated brain tumor segmentation methods have become well-established and reached performance levels offering clear clinical utility. These methods typically rely on four input m…
The ASNR-MICCAI Brain Tumor Segmentation (BraTS) Challenge 2023: Intracranial Meningioma
Dominic LaBella, Maruf Adewole, Michelle Alonso-Basanta +57
Meningiomas are the most common primary intracranial tumor in adults and can be associated with significant morbidity and mortality. Radiologists, neurosurgeons, neuro-oncologists,…
BraTS-PEDs: Results of the Multi-Consortium International Pediatric Brain Tumor Segmentation Challenge 2023
Anahita Fathi Kazerooni, Nastaran Khalili, Xinyang Liu +77
Pediatric central nervous system tumors are the leading cause of cancer-related deaths in children. The five-year survival rate for high-grade glioma in children is less than 20%.…
BraTS-Path Challenge: Assessing Heterogeneous Histopathologic Brain Tumor Sub-regions
Spyridon Bakas, Siddhesh P. Thakur, Shahriar Faghani +19
Glioblastoma is the most common primary adult brain tumor, with a grim prognosis - median survival of 12-18 months following treatment, and 4 months otherwise. Glioblastoma is wide…
Evaluation of software impact designed for biomedical research: Are we measuring what's meaningful?
Awan Afiaz, Andrey Ivanov, John Chamberlin +24
Software is vital for the advancement of biology and medicine. Analysis of usage and impact metrics can help developers determine user and community engagement, justify additional…